2024 Fourth Quarter Outlook: Revenues to increase LSD; CCM – up MSD; CWT – down LSD. Adjusted EBITDA margin ~ 25%
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSL: